Your browser doesn't support javascript.
loading
Association of Time of Day With Outcomes Among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia.
García-Tornel, Álvaro; Flores, Alan; Terceño, Mikel; Cardona, Pedro; Amaro, Sergi; Gomis, Meritxell; Zaragoza, Josep; Krupinski, Jerzy; Gómez-Choco, Manuel; Mas, Natalia; Cocho, Dolores; Catena, Esther; Purroy, Francesc; Deck, Matias; Rubiera, Marta; Pagola, Jorge; Rodriguez-Luna, David; Juega, Jesús; Rodríguez-Villatoro, Noelia; Molina, Carlos A; Soro, Cristina; Jimenez, Xavier; Salvat-Plana, Mercè; Dávalos, Antoni; Jovin, Tudor G; Abilleira, Sonia; Pérez de la Ossa, Natalia; Ribó, Marc.
Afiliação
  • García-Tornel Á; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Flores A; Department of Neurology, Hospital Universitari Joan XXIII, Tarragona, Spain (A.F.).
  • Terceño M; Stroke Unit, Hospital Universitari Josep Trueta, Girona, Spain (M.T.).
  • Cardona P; Stroke Unit, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Spain (P.C.).
  • Amaro S; Stroke Unit, Hospital Clínic, Barcelona, Spain (S.A.).
  • Gomis M; Stroke Unit, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain (M.G., A.D., N.P.d.l.O.).
  • Zaragoza J; Department of Neurology, Hospital Verge de la Cinta, Tortosa, Spain (J.Z.).
  • Krupinski J; Department of Neurology, Hospital Mútua Terrassa, Spain (J.K.).
  • Gómez-Choco M; Department of Neurology, Hospital Moisés Broggi, Sant Joan Despí, Spain (M.G.-C.).
  • Mas N; Department of Neurology, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain (N.M.).
  • Cocho D; Department of Neurology, Hospital General Granollers, Spain (D.C.).
  • Catena E; Department of Neurology, Consorci Sanitari Alt Penedès-Garraf, Spain (E.C.).
  • Purroy F; Stroke Unit, Department of Neurology, Hospital Universitari Arnau de Vilanova de Lleida, Spain (F.P.).
  • Deck M; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Rubiera M; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Pagola J; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Rodriguez-Luna D; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Juega J; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Rodríguez-Villatoro N; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Molina CA; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
  • Soro C; Sistema d'Emergències Mèdiques, Barcelona, Spain (C.S., X.J.).
  • Jimenez X; Sistema d'Emergències Mèdiques, Barcelona, Spain (C.S., X.J.).
  • Salvat-Plana M; Stroke Program, Catalan Health Department, Agency for Health Quality and Assesment of Catalonia (AQuAS), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (M.S.-P., S.A.).
  • Dávalos A; Stroke Unit, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain (M.G., A.D., N.P.d.l.O.).
  • Jovin TG; Neurological Institute, Cooper University Hospital, Camden, NJ (T.G.J.).
  • Abilleira S; Stroke Program, Catalan Health Department, Agency for Health Quality and Assesment of Catalonia (AQuAS), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (M.S.-P., S.A.).
  • Pérez de la Ossa N; Stroke Unit, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain (M.G., A.D., N.P.d.l.O.).
  • Ribó M; Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Spain (A.G.-T., M.D., M. Rubiera., J.P., D.R.L., J.J., N.R.V., C.A.M., M. Ribó).
Stroke ; 54(3): 770-780, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36848432
ABSTRACT

BACKGROUND:

We aim to assess whether time of day modified the treatment effect in the RACECAT trial (Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke Center in Acute Stroke Patients With Suspected Large Vessel Occlusion Trial), a cluster-randomized trial that did not demonstrate the benefit of direct transportation to a thrombectomy-capable center versus nearest local stroke center for patients with a suspected large vessel stroke triaged in nonurban Catalonia between March 2017 and June 2020.

METHODS:

We performed a post hoc analysis of RACECAT to evaluate if the association between initial transport routing and functional outcome differed according to trial enrollment time daytime (800 am-859 pm) and nighttime (900 pm-759 am). Primary outcome was disability at 90 days, as assessed by the shift analysis on the modified Rankin Scale score, in patients with ischemic stroke. Subgroup analyses according to stroke subtype were evaluated.

RESULTS:

We included 949 patients with an ischemic stroke, of whom 258 patients(27%) were enrolled during nighttime. Among patients enrolled during nighttime, direct transport to a thrombectomy-capable center was associated with lower degrees of disability at 90 days (adjusted common odds ratio [acOR], 1.620 [95% CI, 1.020-2.551]); no significant difference between trial groups was present during daytime (acOR, 0.890 [95% CI, 0.680-1.163]; P interaction=0.014). Influence of nighttime on the treatment effect was only evident in patients with large vessel occlusion(daytime, acOR 0.766 [95% CI, 0.548-1.072]; nighttime, acOR, 1.785 [95% CI, 1.024-3.112] ; P interaction<0.01); no heterogeneity was observed for other stroke subtypes (P interaction>0.1 for all comparisons). We observed longer delays in alteplase administration, interhospital transfers, and mechanical thrombectomy initiation during nighttime in patients allocated to local stroke centers.

CONCLUSIONS:

Among patients evaluated during nighttime for a suspected acute severe stroke in non-urban areas of Catalonia, direct transport to a thrombectomy-capable center was associated with lower degrees of disability at 90 days. This association was only evident in patients with confirmed large vessel occlusion on vascular imaging. Time delays in alteplase administration and interhospital transfers might mediate the observed differences in clinical outcome. REGISTRATION URL https//www. CLINICALTRIALS gov; Unique identifier NCT02795962.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Clinical_trials / Evaluation_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Clinical_trials / Evaluation_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article